BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28066411)

  • 1. Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation.
    Ullrich E; Salzmann-Manrique E; Bakhtiar S; Bremm M; Gerstner S; Herrmann E; Bader P; Hoffmann P; Holler E; Edinger M; Wolff D
    Front Immunol; 2016; 7():595. PubMed ID: 28066411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.
    Huenecke S; Cappel C; Esser R; Pfirrmann V; Salzmann-Manrique E; Betz S; Keitl E; Banisharif-Dehkordi J; Bakhtiar S; Königs C; Jarisch A; Soerensen J; Ullrich E; Klingebiel T; Bader P; Bremm M
    Front Immunol; 2017; 8():109. PubMed ID: 28239380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaping of CD56
    Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2019; 10():547. PubMed ID: 30949182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation.
    Imamura M; Tsutsumi Y; Miura Y; Toubai T; Tanaka J
    Hematology; 2003 Feb; 8(1):19-26. PubMed ID: 12623423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.
    Haroun-Izquierdo A; Lanuza PM; Pfefferle A; Netskar H; Ask EH; Törlén J; Björklund A; Sohlberg E; Malmberg KJ
    Transplant Cell Ther; 2023 Jun; 29(6):376.e1-376.e11. PubMed ID: 36966873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhou Z; Liu X; Zhang X; Wen S; Hua H; Wang Z; Xu Z; Lu Y; Wang F
    J Inflamm Res; 2023; 16():2993-3008. PubMed ID: 37489148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors.
    Zhao XY; Chang YJ; Xu LP; Liu DH; Liu KY; Huang XJ
    Bone Marrow Transplant; 2009 Dec; 44(11):721-8. PubMed ID: 19377516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD.
    Chan YLT; Zuo J; Inman C; Croft W; Begum J; Croudace J; Kinsella F; Maggs L; Nagra S; Nunnick J; Abbotts B; Craddock C; Malladi R; Moss P
    Eur J Immunol; 2018 Feb; 48(2):316-329. PubMed ID: 28944953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation.
    Ghasemzadeh M; Hosseini E; Schwarer AP; Pourfathollah AA
    Leuk Res; 2016 Apr; 43():58-65. PubMed ID: 26856773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.
    Dodero A; Carrabba M; Milani R; Rizzo E; Raganato A; Montefusco V; Farina L; Milanesi M; Longoni P; Carlo-Stella C; Corradini P
    Exp Hematol; 2005 Aug; 33(8):920-7. PubMed ID: 16038785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation.
    Pradier A; Cordey S; Zanella MC; Melotti A; Wang S; Mamez AC; Chalandon Y; Masouridi-Levrat S; Kaiser L; Simonetta F; Vu DL
    Front Immunol; 2022; 13():1060886. PubMed ID: 36713419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the specific murine NK cell subset supporting graft-
    Meinhardt K; Kroeger I; Bauer R; Ganss F; Ovsiy I; Rothamer J; Büttner M; Atreya I; Waldner M; Bittrich M; Lehmann CH; Rieger MA; Beilhack A; Zeiser R; Edinger M; Dudziak D; Mackensen A; Rehli M; Ullrich E
    Oncoimmunology; 2015 Jan; 4(1):e981483. PubMed ID: 25949862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
    Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of CD56
    Maggs L; Kinsella F; Chan YLT; Eldershaw S; Murray D; Nunnick J; Bird J; Craddock C; Zuo J; Malladi R; Moss P
    Blood Adv; 2017 Aug; 1(19):1589-1597. PubMed ID: 29296800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
    Malard F; Szydlo RM; Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Mohty M
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):28-34. PubMed ID: 20053329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of NK cells in allogeneic hematopoietic stem cell transplantation--review].
    Li XH; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):845-8. PubMed ID: 16928336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.